Who founded Moleculin?

Moleculin was founded by Wally Klemp in 2006.

How much funding has Moleculin raised?

Moleculin has disclosed $1.4M raised across 1 round.

Where is Moleculin headquartered?

Moleculin is headquartered in Houston, US.

Moleculin

Houston, US · Founded 2006 · 22 employees on LinkedIn

Find your way into Moleculin

62 people in our graph share verified history with the Moleculin team — schools, employers, funds. One of them is your warm intro.

Jeremy Touroounlockedknows Lori H Bisson · together at Autonomix Medical (overlapped)

knows the team · via Soliton, Inc.

×8knows the team · via Lewis & Clark College

knows the team · via Baylor University - Hankamer School of Business

knows the team · via Autonomix Medical

Moleculin Biotech is a Phase 3 clinical-stage biopharmaceutical company developing therapeutic candidates for hard-to-treat tumors and viruses, with a lead program (Annamycin) targeting relapsed or refractory acute myeloid leukemia and soft tissue sarcoma.

Biotech Medical Devices

Founders & leadership

Moleculin was founded in 2006 by Wally Klemp.

Wally Klemp Chairman & CEOWally Klemp is Chairman and CEO of Moleculin Biotech, a clinical-stage biopharmaceutical company developing therapeutics for hard-to-treat tumors and viruses. He has prior experience in pharmaceuticals and medical device sectors across drug development, financing, and international business.

Donald PickerExecutive

Lori H Bisson Assistant Secretary-Treasurer and AdvisorLori H Bisson is an executive with extensive experience in the life sciences industry, including public company leadership, capital markets transactions, M&A, and board governance. She serves as Executive Officer and Director of Moleculin Biotech, a Phase 3 clinical-stage biopharmaceutical company developing therapeutic candidates for difficult-to-treat tumors and viruses.

Board

Michael ClinardBoard director

Robert ConradBoard director

Stephen DrakeBoard director

J. George GumulkaBoard director

Reported raises · per SEC filings

Form D private placements

$1.4M disclosed across 1 round · 2014

▶$1.4MraisedOct 2014 · 36 investors · Pharmaceuticals

Officers, directors & promoters on the filing

Walter V KlempExecutive Officer, Director
Michael ClinardDirector
Robert ConradDirector
Stephen DrakeDirector
J. George GumulkaDirector
Donald PickerExecutive Officer, Director
Lori H BissonExecutive Officer, Director

Offering amount: $2M
Amount sold: $1.4M
Minimum investment: $5K
Finders' fees: $60K
First sale: May 2014
Incorporated: Limited Liability Company, Texas
Federal exemptions: 05

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Moleculin do?: Moleculin Biotech is a Phase 3 clinical-stage biopharmaceutical company developing therapeutic candidates for hard-to-treat tumors and viruses, with a lead program (Annamycin) targeting relapsed or refractory acute myeloid leukemia and soft tissue sarcoma.
Who founded Moleculin?: Moleculin was founded by Wally Klemp in 2006.
How much funding has Moleculin raised?: Moleculin has disclosed $1.4M raised across 1 round.
Where is Moleculin headquartered?: Moleculin is headquartered in Houston, US.